Background
WHO’s Product Development for Vaccines Advisory Committee (PDVAC) meetings were being convened virtually over the course of 2021 with each meeting covering a particular subject matter. The meetings held include:
- Review of Preferred Product Characteristics (PPCs) for HIV monoclonal antibodies, 15-16 April 2021;
- WHO mechanisms to support manufacture of and access to mRNA vaccines in Low- and Middle-Income Countries (LMICs), 5 November 2021.
Executive summaries of the meetings as well as the agenda, list of participants and presentations can be found below:
Review of PPC for HIV monoclonal antibodies
WHO mechanisms to support manufacture of and access to mRNA vaccines in LMICs